We calculated the half inhibitory concentration (IC50) of DDD85646 on EGFR mutant (H1975 and H1650) and KRAS/EGFR wild-type lung carcinoma cells (H1299 and H522) at 72 hours of treatment. The gene discussed is KRAS; the disease is lung carcinoma.